苄基-(3,4-二甲氧基苄基)胺 | 13174-24-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 苄基-(3,4-二甲氧基苄基)胺
• 英文名称: N-benzyl-N-(3,4-dimethoxybenzyl)amine
• 英文别名: Benzyl-(3,4-dimethoxy-benzyl)-amine；N-[(3,4-dimethoxyphenyl)methyl]-1-phenylmethanamine
• CAS: 13174-24-8
• 化学式: C₁₆H₁₉NO₂
• mdl: MFCD01049058
• 分子量: 257.332
• InChiKey: JUVDVCSGIUHGPB-UHFFFAOYSA-N

物化性质

• 沸点：
  372.0±32.0 °C(Predicted)
• 密度：
  1.073±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  30.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2922299090

反应信息

• 作为反应物：
  描述：

  苄基-(3,4-二甲氧基苄基)胺 在 potassium carbonate 作用下， 以 四氢呋喃 为溶剂， 生成 2,6-bis(diethanoloamino)-4,8-di-(N-benzyl-N-3',4'-dimethoxybenzylamino)pyrimido[5,4-d]pyrimidine
  参考文献：
  名称：

  Resistance-Modifying Agents. 11. Pyrimido[5,4-d]pyrimidine Modulators of Antitumor Drug Activity. Synthesis and Structure−Activity Relationships for Nucleoside Transport Inhibition and Binding to α₁-Acid Glycoprotein

  摘要：

  The cardiovascular and antithrombotic agent dipyridamole (DP) has potential therapeutic utility as a modulator of the activity of antimetabolite antitumor agents by virtue of its inhibition of nucleoside transport. However, the activity of DP can be compromised by binding to the acute phase serum protein, alpha(1)-acid glycoprotein (AGP). Analogues of DP were synthesized and evaluated as inhibitors of H-3-thymidine uptake into L1210 leukamia cells in the presence and absence of 5 mg/mL AGP. Compounds with potency similar to that of DP were identified where the piperidino substituents at the 4,8-positions were replaced by 4'-methoxybenzylamino, 3',4'dimethoxybenzylamino, or piperonylamino groups. Replacement of the diethanolamino groups at the 2,6-positions of DP by alkylamino or alkoxy substituents was tolerated, although at least one oxygen-bearing function (hydroxyl or alkoxy) was required in the side chain for activity comparable to that of DP. Whereas AGP completely ablated the activity of DP, the majority of the newer compounds synthesized retained significant activity in the presence of excess AGP, although replacement of the piperidino groups at the 4,8-positions by N-methylbenzylamino substituents did, in some cases, restore susceptibility to AGP. Selected compounds have been demonstrated to prevent rescue from antifolate cytotoxicity, mediated by nucleoside salvage.

  DOI：

  10.1021/jm040772w
• 作为产物：
  描述：

  3,4-二甲氧基苯甲醛 在 sodium tetrahydroborate 作用下， 以 乙醇 、 苯 为溶剂， 反应 3.0h， 生成 苄基-(3,4-二甲氧基苄基)胺
  参考文献：
  名称：

  Simple Synthetic Equivalents for the β-(N,N-Disubstituted)ethylamino Acyl Cation Synthon and their Applications

  摘要：

  合成了多种N,N-二取代的β-氨基-N-甲氧基-N-甲基丙酰胺3a-i，它们作为优秀的β-氨基酰基阳离子等价物。这些化合物被用于制备β-氨基酮1，具有药理活性的三级1-(3,3-二芳基丙基)胺7a-c，以及有趣的C-糖苷8。

  DOI：

  10.1055/s-2001-18439

文献信息

• Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors
  作者：Galina F. Makhaeva、Natalia P. Boltneva、Sofya V. Lushchekina、Olga G. Serebryakova、Tatyana S. Stupina、Alexey A. Terentiev、Igor V. Serkov、Alexey N. Proshin、Sergey O. Bachurin、Rudy J. Richardson

  DOI：10.1016/j.bmc.2016.01.031

  日期：2016.3

  A series of 31 N,N-disubstituted 2-amino-5-halomethyl-2-thiazolines was designed, synthesized, and evaluated for inhibitory potential against acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and carboxylesterase (CaE). The compounds did not inhibit AChE; the most active compounds inhibited BChE and CaE with IC50 values of 0.22–2.3 μM. Pyridine-containing compounds were more selective toward

  设计，合成了一系列31 N，N-二取代的2-氨基-5-卤甲基-2-噻唑啉，并评估了其对乙酰胆碱酯酶（AChE），丁酰胆碱酯酶（BChE）和羧酸酯酶（CaE）的抑制潜力。该化合物不抑制AChE。最具活性的化合物抑制BChE和CaE，IC 50值为0.22–2.3μM。含吡啶的化合物对BChE的选择性更高。与对位的化合物两个二苄基片段之一中的-OMe取代基对CaE的选择性更高。碘化衍生物比溴化衍生物更有效的BChE抑制剂，而卤素类型对CaE的抑制作用没有影响。对9种活性最高的化合物的抑制动力学表明，CaE的竞争性是非竞争性的，而BChE的抑制机制（竞争性，非竞争性或混合型）多种多样。对接模拟预测了化合物与BChE和CaE的关键结合相互作用，并揭示了BChE中最佳的对接位置是在峡谷底部靠近活性位点的催化残基。相反，CaE的最佳结合位置聚集在距离峡谷顶部的活性位点很远的位置。因此，对接结果提供了对
• An intramolecular C(sp³)–H imination using PhI–<i>m</i>CPBA
  作者：Anima Bose、Saikat Maiti、Sudip Sau、Prasenjit Mal

  DOI：10.1039/c8cc09100e

  日期：——

  Development of sustainable methods for the activation of less reactive undirected C(sp³)–H bonds is challenging but desired in organic synthesis. The present manuscript demonstrates selective activation of acidic C(sp³)–H groups for a dehydrogenative C–H imination reaction by 4H elimination using PhI (10 mol%)–mCPBA as an organocatalyst.

  开发可持续方法来活化较不活泼的无向C(sp³)–H键在有机合成中具有挑战性但是受欢迎。本手稿展示了使用PhI (10 mol%)–mCPBA作为有机催化剂进行脱氢C–H亚胺化反应，实现对酸性C(sp³)–H基团的选择性活化。
• COMPOUND
  申请人：Jourdan Fabrice

  公开号：US20100222299A1

  公开（公告）日：2010-09-02

  The present invention involves tetrahydroisoquinoline compounds and their use in the inhibition and/or prevention of tumor growth.

  本发明涉及四氢异喹啉化合物及其在抑制和/或预防肿瘤生长中的应用。
• Compound
  申请人：Leese Matthew

  公开号：US08394825B2

  公开（公告）日：2013-03-12

  The present invention involves tetrahydroisoquinoline compounds and their use in the inhibition and/or prevention of tumor growth.

  本发明涉及四氢异喹啉化合物及其在抑制和/或预防肿瘤生长中的应用。
• WO2008/117061
  申请人：——

  公开号：——

  公开（公告）日：——